Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Obesity is a chronic metabolic disease affecting adults and children worldwide. It has become one of the leading causes of death, as obesity is known to be the main risk factor for a number of non-communicable diseases, in particular type 2 diabetes. This close relationship led to the connotation ‘diabesity', highlighting the fact that the majority of individuals with diabetes are overweight or obese. Until today the BMI is still used to classify overweight and obesity. Since reduced muscle mass is highly prevalent throughout the BMI range, the measurement of body composition is strongly recommended. Moreover, it is essential for monitoring the course of weight reduction, which is part of every effective anti-obesity treatment. Weight reduction can be achieved via different weight loss strategies, including lifestyle intervention (diet and exercise), pharmacotherapy, or bariatric surgery. However, not all of these strategies are suitable for all patients, and any further needs should be considered. Besides, attention should also be drawn to concomitant therapies. These therapies may promote additional weight gain and further trigger the deterioration of blood glucose control. Thus, therapeutic strategies are warranted, which can be easily used for the management of obese patients with type 2 diabetes to achieve their glycemic and weight loss goals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity and T2D share key pathophysiological mechanisms and are both associated with increased risk for (i) metabolic complications [such as hypertension, dyslipidemia, obstructive sleep apnea (OSA) and metabolic-dysfunction associated steatotic liver disease (MASLD)] and (ii) cardiovascular disease [2,4].”
In the citing paper
“Obesity and T2D share key pathophysiological mechanisms and are both associated with increased risk for (i) metabolic complications [such as hypertension, dyslipidemia, obstructive sleep apnea (OSA) and metabolic-dysfunction associated steatotic liver disease (MASLD)] and (ii) cardiovascular disease [2,4].”
In the citing paper
“Obesity is the strongest risk factor for T2D and the obesity epidemic is heavily contributed to the rise of T2D prevalence, especially the increased rates of young-onset T2D [2].”
In the citing paper
“Obesity is the strongest risk factor for T2D and the obesity epidemic is heavily contributed to the rise of T2D prevalence, especially the increased rates of young-onset T2D [2].”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Self-citationGlobal burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
Shai, I., Schwarzfuchs, D., Henkin, Y., Shahar, D. R., Witkow, S., Greenberg, I., Golan, R., Fraser, D., Bolotin, A., Vardi, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708681 · Cited by 2,143
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Blundell, J. E., Baker, J. L., Boyland, E., Blaak, E., Charzewska, J., de Henauw, S., Frühbeck, G., Gonzalez-Gross, M., Hebebrand, J., Holm, L., et al. (2017) · Obesity Facts · doi:10.1159/000455952 · Cited by 1,945
Self-citationThe Finnish Diabetes Prevention Study (DPS)
Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3230 · Cited by 1,848
Wing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2415 · Cited by 1,828
Dansinger, M. L., Gleason, J. A., Griffith, J. L., Selker, H. P., & Schaefer, E. J. (2005) · JAMA · doi:10.1001/jama.293.1.43 · Cited by 1,726
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.334 · Cited by 1,162
SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes
Malmstrom, T. K., Miller, D. K., Simonsick, E. M., Ferrucci, L., & Morley, J. E. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12048 · Cited by 1,155
Sarcopenia in daily practice: assessment and management
Beaudart, C., McCloskey, E., Bruyère, O., Cesari, M., Rolland, Y., Rizzoli, R., Araujo de Carvalho, I., Amuthavalli Thiyagarajan, J., Bautmans, I., Bertière, M.-C., et al. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0349-4 · Cited by 850
Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study
The Look AHEAD Research Group (2014) · Obesity · doi:10.1002/oby.20662 · Cited by 842
Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery
on behalf of International Federation for the Surgery of Obesity and Metabolic Disorders—European Chapter (IFSO-EC) and European Association for the Study of Obesity (EASO), Fried, M., Yumuk, V., Oppert, J. M., Scopinaro, N., Torres, A., Weiner, R., Yashkov, Y., & Frühbeck, G. (2014) · Obesity Surgery · doi:10.1007/s11695-013-1079-8 · Cited by 753
Self-citationMattson, R. H., Cramer, J. A., & Collins, J. F. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209103271104 · Cited by 683
Gómez-Ambrosi, J., Silva, C., Galofré, J. C., Escalada, J., Santos, S., Millán, D., Vila, N., Ibañez, P., Gil, M. J., Valentí, V, et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.100 · Cited by 615
Self-citationMorley, J. E., Anker, S. D., & von Haehling, S. (2014) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-014-0161-y · Cited by 608
Intentional weight loss and mortality among overweight individuals with diabetes.
Williamson, D. F., Thompson, T. J., Thun, M., Flanders, D., Pamuk, E., & Byers, T. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1499 · Cited by 558
Foster, G. D. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.266 · Cited by 538
Lithium side effects and toxicity: prevalence and management strategies
Gitlin, M. (2016) · International Journal of Bipolar Disorders · doi:10.1186/s40345-016-0068-y · Cited by 531
One-year weight losses in the Look AHEAD study: factors associated with success
Wadden, T. A., West, D. S., Neiberg, R. H., Wing, R. R., Ryan, D. H., Johnson, K. C., Foreyt, J. P., Hill, J. O., Trence, D. L., Vitolins, M. Z., et al. (2009) · Obesity · doi:10.1038/oby.2008.637 · Cited by 525
Willis, L. H., Slentz, C. A., Bateman, L. A., Shields, A. T., Piner, L. W., Bales, C. W., Houmard, J. A., & Kraus, W. E. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01370.2011 · Cited by 496
Esposito, K., Ida Maiorino, M., Ciotola, M., Di Palo, C., Scognamiglio, P., Gicchino, M., Petrizzo, M., Saccomanno, F., Beneduce, F., Ceriello, A., et al. (2010) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3181e5a159 · Cited by 460
Management of Obesity in Adults: European Clinical Practice Guidelines
Tsigos, C., Hainer, V., Basdevant, A., Finer, N., Fried, M., Mathus-Vliegen, E., Micic, D., Maislos, M., Roman, G., Schutz, Y., et al. (2008) · Obesity Facts · doi:10.1159/000126822 · Cited by 443
Self-citationCawthon, P. M., Fox, K. M., Gandra, S. R., Delmonico, M. J., Chiou, C., Anthony, M. S., Sewall, A., Goodpaster, B., Satterfield, S., Cummings, S. R., et al. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02366.x · Cited by 414
Hypothesis: β-Adrenergic Receptor Blockers and Weight Gain: A Systematic Analysis
Sharma, A. M., Pischon, T., Hardt, S., Kunz, I., & Luft, F. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.250 · Cited by 338
Obesity, weight loss and prognosis in type 2 diabetes
Lean, M. E. J., Powrie, J. K., Anderson, A. S., & Garthwaite, P. H. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01375.x · Cited by 318
Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery
Fried, M., Yumuk, V., Oppert, J.-M., Scopinaro, N., Torres, A. J., Weiner, R., Yashkov, Y., & Frühbeck, G. (2013) · Obesity Facts · doi:10.1159/000355480 · Cited by 316
Self-citationEXERCISE IN WEIGHT MANAGEMENT OF OBESITY
Poirier, P., & Després, J.-P. (2001) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70229-0 · Cited by 272
Frühbeck, G., Toplak, H., Woodward, E., Yumuk, V., Maislos, M., Oppert, J.-M., & for the Executive Committee of the European Association for the Study of Obesity (2013) · Obesity Facts · doi:10.1159/000350627 · Cited by 264
Self-citationEeg-Olofsson, K., Cederholm, J., Nilsson, P. M., Zethelius, B., Nunez, L., Gudbjörnsdóttir, S., & Eliasson, B. (2009) · Diabetologia · doi:10.1007/s00125-008-1190-x · Cited by 254
Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment
Van Gaal, L., & Scheen, A. (2015) · Diabetes Care · doi:10.2337/dc14-1630 · Cited by 221
The Look AHEAD Research Group (2014) · Diabetes Care · doi:10.2337/dc13-1928 · Cited by 217
Weight issues for people with epilepsy—A review
Ben‐Menachem, E. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01402.x · Cited by 206
Resch, K. (2008) · PubMed · Cited by 202
Larsen, R. N., Mann, N. J., Maclean, E., & Shaw, J. E. (2011) · Diabetologia · doi:10.1007/s00125-010-2027-y · Cited by 197
Beyond BMI - Phenotyping the Obesities
Blundell, J. E., Dulloo, A. G., Salvador, J., Frühbeck, G., & on behalf of the EASO SAB Working Group on BMI, G. (2014) · Obesity Facts · doi:10.1159/000368783 · Cited by 197
Self-citationTsai, S. A., Lv, N., Xiao, L., & Ma, J. (2015) · American Journal of Men s Health · doi:10.1177/1557988314567223 · Cited by 180
Diabetes medications and body weight
Mitri, J., & Hamdy, O. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903081725 · Cited by 146
Krebs, J. D., Elley, C. R., Parry-Strong, A., Lunt, H., Drury, P. L., Bell, D. A., Robinson, E., Moyes, S. A., & Mann, J. I. (2012) · Diabetologia · doi:10.1007/s00125-012-2461-0 · Cited by 137
Berthon, B. S., MacDonald‐Wicks, L. K., & Wood, L. G. (2014) · Nutrition Research · doi:10.1016/j.nutres.2013.12.006 · Cited by 135
Berenson, A. B., & Rahman, M. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.12.052 · Cited by 134
Changes in Body Weight With Chronic, High-Dose Gabapentin Therapy
DeToledo, J. C., Toledo, C., DeCerce, J., & Ramsay, R. E. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199708000-00006 · Cited by 129
Fat or Fit: What Is More Important?
Hainer, V., Toplak, H., & Štich, V. (2009) · Diabetes Care · doi:10.2337/dc09-s346 · Cited by 126
Self-citationWeight Gain in Epileptic Patients During Treatment with Valproic Acid: a Retrospective Study
Corman, C., Leung, N. M., & Guberman, A. H. (1997) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100021879 · Cited by 126
Pérez‐Iglesias, R., Crespo‐Facorro, B., Martínez‐García, O., Ramírez-Bonilla, M. L., Álvarez‐Jiménez, M., Pelayo‐Terán, J. M., García‐Unzueta, M. T., Amado, J., & Vázquez‐Barquero, J. L. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.022 · Cited by 121
Weight Gain with Antidepressants and Lithium
Garland, E., Remick, R. A., & Zis, A. P. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198810000-00003 · Cited by 119
An EASO Position Statement on Multidisciplinary Obesity Management in Adults
Yumuk, V., Frühbeck, G., Oppert, J., Woodward, E., & Toplak, H. (2014) · Obesity Facts · doi:10.1159/000362191 · Cited by 119
Self-citationTwelve key nutritional issues in bariatric surgery
Thibault, R., Huber, O., Azagury, D. E., & Pichard, C. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2015.02.012 · Cited by 116
Oldridge, N. B., Stump, T. E., Nothwehr, F. K., & Clark, D. O. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00350-x · Cited by 113
The therapeutics of lifestyle management on obesity
Dyson, P. A. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01256.x · Cited by 105
Drug Induced Weight Gain, an Impediment to Successful Pharmacotherapy: Focus on Antipsychotics
Baptista, T., Zarate, J. M., Joober, R., Colasante, C., Beaulieu, S., Páez, X., & Hernandez, L. (2004) · Current Drug Targets · doi:10.2174/1389450043490514 · Cited by 99
2014 EASO Position Statement on the Use of Anti-Obesity Drugs
Toplak, H., Woodward, E., Yumuk, V., Oppert, J., Halford, J. C. G., & Frühbeck, G. (2015) · Obesity Facts · doi:10.1159/000430801 · Cited by 97
Self-citationValproate, weight gain and carbohydrate craving: A gender study
El-Khatib, F., Rauchenzauner, M., Lechleitner, M., Hoppichler, F., Naser, A., Waldmann, M., Trinka, E., Unterberger, I., Bauer, G. J., & Luef, G. J. (2007) · Seizure · doi:10.1016/j.seizure.2006.12.009 · Cited by 90
The association between weight change and symptom reduction in the CATIE schizophrenia trial
Hermes, E. D. A., Nasrallah, H. A., Davis, V. G., Meyer, J. M., McEvoy, J. P., GOFF, D. C., Thomas, S., Stroup, T. S., Swartz, M. S., Lieberman, J. A., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.01.022 · Cited by 88
Sjöholm, K., Pajunen, P., Jacobson, P., Karason, K., Sjöström, C. D., Torgerson, J., Carlsson, L. M. S., Sjöström, L., & Peltonen, M. (2015) · Diabetologia · doi:10.1007/s00125-015-3591-y · Cited by 86
Renal and Vascular Mechanisms of Thiazolidinedione‐Induced Fluid Retention
Yang, T., & Soodvilai, S. (2008) · PPAR Research · doi:10.1155/2008/943614 · Cited by 75
Antiepileptic drugs influences on body weight in people with epilepsy
Hamed, S. A. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.991716 · Cited by 72
Handgrip Strength as a Predictor for Post Bariatric Body Composition
Otto, M., Kautt, S., Kremer, M., Kienle, P., Post, S., & Hasenberg, T. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1299-6 · Cited by 53
Cut‐points for Waist Circumference in Europids and South Asians
Cameron, A. J., Sicree, R. A., Zimmet, P., Alberti, K. G. M. M., Tonkin, A. M., Balkau, B., Tuomilehto, J. O., Chitson, P., & Shaw, J. E. (2009) · Obesity · doi:10.1038/oby.2009.455 · Cited by 49
Weight Gain, Increased Appetite, and Excessive Food Intake Induced by Carbamazepine
Lampl, Y., Eshel, Y., Rapaport, A., & Sarova-Pinhas, I. (1991) · Clinical Neuropharmacology · doi:10.1097/00002826-199106000-00009 · Cited by 47
Baulac, M. (1998) · Seizure · doi:10.1016/s1059-1311(98)90009-7 · Cited by 45
Modification in body weight associated with antiepileptic drugs
de Gaspari, C. N., & Guerreiro, C. A. M. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000200024 · Cited by 35
Wycherley, T. P., Buckley, J. D., Noakes, M., Clifton, P. M., & Brinkworth, G. D. (2014) · Journal of the American College of Nutrition · doi:10.1080/07315724.2014.911668 · Cited by 32
Toplak, H., Hoppichler, F., Wascher, T. C., Schindler, K., & Ludvik, B. H. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-0986-9 · Cited by 25
Self-citationJensen-Otsu, E., & Austin, G. L. (2015) · Nutrients · doi:10.3390/nu7115489 · Cited by 23
Dambkowski, C. L., Geliebter1, A., 2, Ochner1, 3. C. N., Hashim2, 2. C. L. D. A. S. A., & Internationals, O. (2019) · doi:10.15436/2376-0494.14.001 · Cited by 22
Psychische Erkrankungen und Diabetes mellitus
Abrahamian, H., Kautzky‐Willer, A., Rießland-Seifert, A., Fasching, P., Ebenbichler, C. F., Hofmann, P., & Toplak, H. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0939-8 · Cited by 21
Self-citationManaboriboon, B., Silverman, E. D., Homsanit, M., Chui, H. T., & Kaufman, M. E. (2012) · Lupus · doi:10.1177/0961203312469260 · Cited by 20
Esposito, K., Maiorino, M. I., Ciotola, M., Di Palo, C., Scognamiglio, P., Gicchino, M., Petrizzo, M., Saccomanno, F., Beneduce, F., Ceriello, A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-5-200909010-00004 · Cited by 13
Global Obesity Study on Drivers for Weight Reduction Strategies
Grebitus, C., Hartmann, M., & Reynolds, N. (2015) · Obesity Facts · doi:10.1159/000373905 · Cited by 9
The Role of Weight Loss in the Management of Type 2 Diabetes
Franz, M. J. (2016) · US Endocrinology · doi:10.17925/use.2016.12.01.14 · Cited by 4
Cited by
The Role of Obesity in Type 2 Diabetes Mellitus—An Overview
Chandrasekaran, P., & Weiskirchen, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031882 · Cited by 465
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus
Magkos, F., Hjorth, M. F., & Astrup, A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0381-5 · Cited by 469
Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma, S., & Tripathi, P. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.10.003 · Cited by 428
Marine Collagen as A Promising Biomaterial for Biomedical Applications
Lim, Y.-S., Ok, Y.-J., Hwang, S.-Y., Kwak, J.-Y., & Yoon, S. (2019) · Marine Drugs · doi:10.3390/md17080467 · Cited by 328
“Obesity is known to be the main risk factor not only for a number of non-communicable diseases like type-2 diabetes mellitus (T2DM), cardiovascular disease, hypertension, coronary heart disease, or certain types of cancers but also for diverse psychological problems and various physical disabilities [162].”
BackgroundErectile dysfunction and diabetes: A melting pot of circumstances and treatments
Defeudis, G., Mazzilli, R., Tenuta, M., Rossini, G., Zamponi, V., Olana, S., Faggiano, A., Pozzilli, P., Isidori, A. M., & Gianfrilli, D. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3494 · Cited by 285
Metadata
- Authors
- Leitner, D. R., Frühbeck, G., Yumuk, V., Schindler, K., Micic, D., Woodward, E., & Toplak, H.
- Affiliations
- University of Graz (AT)
- Instituto de Salud Carlos III (ES)
- Istanbul University-Cerrahpaşa (TR)
- Medical University of Vienna (AT)
- European Association for the Study of Obesity (GB)
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 10
- Issue
- 5
- Pages
- 483-492
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- PMC
- PMC5741209
- OpenAlex
- W2762120405
- Cited by
- 431
- References
- 76
- Citations by year
- 2026: 16 · 2025: 51 · 2024: 67 · 2023: 80 · 2022: 76 · 2021: 68 · 2020: 51 · 2019: 14 · 2018: 8
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Obesity Facts (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, type 2 diabetes, diabesity, body composition, weight loss, lifestyle intervention, pharmacotherapy, bariatric surgery, glycemic control
- MeSH terms
- Adult, Child, Combined Modality Therapy, Diabetes Mellitus, Type 2, Diet, Health Services Needs and Demand, Humans, Life Style, Obesity, Exercise, Comorbidity, Anti-Obesity Agents, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.